Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2 1

Status

Not yet recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 3

Conditions

Ovarian Neoplasms 9Parkinson Disease 4, Autosomal Dominant Lewy Body 3Fallopian Tube Neoplasms 3Advanced Ovarian Cancer 3Uterine Neoplasms 2Uterine Cervical Neoplasms 2Pain, Postoperative 2Vomiting 1Thromboembolism 1Primary Peritoneal Neoplasm 1Postoperative Hemorrhage 1Peritoneal Neoplasms 1Peripheral Nervous System Diseases 1Pelvic Neoplasms 1Neoplasm Metastasis 1Myofibroma 1Disease Progression 1Carcinoma, Ovarian Epithelial 1Blood Loss, Surgical 1

Interventions

Saline Solution 3Carboplatin 2Bevacizumab 2talazoparib 1stenoparib 1senaparib 1sargramostim 1olaparib 1niraparib 1liposomal doxorubicin 1Tranexamic Acid 1Ropivacaine 1Paclitaxel 1Observation 1Neoadjuvant Therapy 1Hyperthermic Intraperitoneal Chemotherapy 1Antineoplastic Agents 11-dodecylpyridoxal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Advanced Ovarian Cancer × Saline Solution × Gynecologic × Clear all
NCT04065009 2024-01-11

IPLA-OVCA

Karolinska Institutet

Phase 3 Active not recruiting
220 enrolled
Gynecologic

Advanced Ovarian Cancer

NCT05794659 2023-07-20

Cornerstone4

Aston Sci. Inc.

Phase 2 Not yet recruiting
98 enrolled
Gynecologic

Advanced Ovarian Cancer

NCT04360629 2022-06-01

Efficacy and Safety of Tranexamic Acid in Cytoreductive Surgery for Ovarian Cancer

Fudan University

Phase NA Completed
151 enrolled
Gynecologic

Advanced Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡